prostate cancer

You have access
Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis
MANUEL M. GARRIDO, RUY M. RIBEIRO, KIMBERLY KRÜGER, LUÍS C. PINHEIRO, JOÃO T. GUIMARÃES and STEFAN HOLDENRIEDER

In Vivo July 2021, 35 (4) 2207-2212; DOI: https://doi.org/10.21873/invivo.12492
You have access
A Ten-year-long Update on Radiation Proctitis Among Prostate Cancer Patients Treated With Curative External Beam Radiotherapy
GIANLUCA FERINI and STEFANO PERGOLIZZI

In Vivo May 2021, 35 (3) 1379-1391; DOI: https://doi.org/10.21873/invivo.12390
You have access
Effects of Curcumin Combined With the 5-alpha Reductase Inhibitor Dutasteride on LNCaP Prostate Cancer Cells
AKINORI NAKAYAMA, HISAMITSU IDE, YAN LU, AYANO TAKEI, KAZUNORI FUKUDA, AKIYOSHI OSAKA, GAKU ARAI, SHIGEO HORIE, HIROSHI OKADA and KAZUTAKA SAITO

In Vivo May 2021, 35 (3) 1443-1450; DOI: https://doi.org/10.21873/invivo.12396
You have access
Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines
CHEN-YING SU, GWO-CHE HUANG, YOU-CHENG CHANG, YU-JEN CHEN and HSU-WEI FANG

In Vivo May 2021, 35 (3) 1545-1548; DOI: https://doi.org/10.21873/invivo.12408
You have access
Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/ml
HIROSHI MASUDA, KOSUKE MIKAMI, KOTARO OTSUKA, KYOKUSIN HOU, TAKAHITO SUYAMA, KAZUHIRO ARAKI, SATOKO KOJIMA and YUKIO NAYA

In Vivo May 2021, 35 (3) 1641-1646; DOI: https://doi.org/10.21873/invivo.12422
You have access
Acute Toxicity in Hypofractionated/Stereotactic Prostate Radiotherapy of Elderly Patients: Use of the Image-guided Radio Therapy (IGRT) Clarity System
ROSSELLA DI FRANCO, VALENTINA BORZILLO, DOMINGO ALBERTI, GIANLUCA AMETRANO, ANGELA PETITO, ANDREA COPPOLARO, ILARIA TARANTINO, SABRINA ROSSETTI, SANDRO PIGNATA, GELSOMINA IOVANE, SISTO PERDONÀ, GIUSEPPE QUARTO, GIOVANNI GRIMALDI, ALESSANDRO IZZO, LUIGI CASTALDO, RAFFAELE MUSCARIELLO, MARCELLO SERRA, GAETANO FACCHINI and PAOLO MUTO

In Vivo May 2021, 35 (3) 1849-1856; DOI: https://doi.org/10.21873/invivo.12447
You have access
Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
NAOHIRO FUJIMOTO, MASAKI SHIOTA, TAKUO MATSUKAWA, AKINORI MINATO, IKKO TOMISAKI, REI OHNISHI and MASATOSHI ETO

In Vivo March 2021, 35 (2) 1101-1108; DOI: https://doi.org/10.21873/invivo.12355
You have access
Prognostic Factors in Hormone-sensitive Prostate Cancer Patients Treated With Combined Androgen Blockade: A Consecutive 15-year Study at a Single Japanese Institute
YOSHIYUKI MIYAZAWA, YOSHITAKA SEKINE, SEIJI ARAI, DAISUKE OKA, HIROSHI NAKAYAMA, TAKAHIRO SYUTO, MASASHI NOMURA, HIDEKAZU KOIKE, HIROSHI MATSUI, YASUHIRO SHIBATA and KAZUHIRO SUZUKI

In Vivo January 2021, 35 (1) 373-384; DOI: https://doi.org/10.21873/invivo.12268
You have access
Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer
KAZUMA KOBAYASHI, NAOYA MURAKAMI, KANA TAKAHASHI, KOJI INABA, HIROSHI IGAKI, RYUJI HAMAMOTO and JUN ITAMI

In Vivo January 2021, 35 (1) 489-497; DOI: https://doi.org/10.21873/invivo.12283
You have access
Predicting Biochemical Failure in Irradiated Patients With Prostate Cancer by Tumour Volume Measured by Multiparametric MRI
BENEDICT OERTHER, MORITZ V. BUREN, CHRISTINA M. KLEIN, SIMON KIRSTE, NILS H. NICOLAY, TANJA SPRAVE, SIMON SPOHN, DEEPA DARSHINI GUNASHEKAR, LEONARD HAGELE, LARS BIELAK, MICHAEL BOCK, ANCA-L. GROSU, FABIAN BAMBERG, MATTHIAS BENNDORF and CONSTANTINOS ZAMBOGLOU

In Vivo November 2020, 34 (6) 3473-3481; DOI: https://doi.org/10.21873/invivo.12187

Main menu

User menu

Search

prostate cancer

Pages